GLGLENVIEW CAPITAL MANAGEMENT, LLC
Institutional investor · Portfolio as of Q3 2019
Top Holdings49 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
THE CIGNA GROUP | 5.1M | $779M | 8.2% | $160.84 | -14.99% | 4 qtrssince 2018-Q4 | Increased 65 |
HCA HOLDINGS INC | 5.3M | $643.1M | 6.8% | $117.03 | -3.47% | 4 qtrssince 2018-Q4 | Increased 66 |
MCKESSON CORP | 4M | $547.3M | 5.8% | $105.01 | +23.63% | 4 qtrssince 2018-Q4 | Decreased 0 |
IQVIA HOLDINGS INC | 3.6M | $540.4M | 5.7% | $113.91 | +30.15% | 4 qtrssince 2018-Q4 | Decreased 0 |
TAKEDA PHARMACEUTIC-SP ADR | 27.4M | $472M | 5.0% | $18.94 | -14.29% | 3 qtrssince 2019-Q1 | Increased 61 |
TENET HEALTHCARE CORP | 19.5M | $430.8M | 4.5% | $17.67 | +23.50% | 4 qtrssince 2018-Q4 | Increased 63 |
HOLOGIC INC | 8.2M | $414.5M | 4.4% | $41.07 | +20.78% | 4 qtrssince 2018-Q4 | Decreased 0 |
HUMANA INC | 1.6M | $408.9M | 4.3% | $252.45 | -3.34% | 4 qtrssince 2018-Q4 | Decreased 0 |
FMC CORP | 4.3M | $375.6M | 4.0% | $52.60 | +36.80% | 4 qtrssince 2018-Q4 | Decreased 0 |
DXC TECHNOLOGY CO | 11.8M | $348M | 3.7% | $51.00 | -43.07% | 4 qtrssince 2018-Q4 | Increased 63 |
BAUSCH HEALTH COS INC | 13.8M | $301.8M | 3.2% | $21.01 | +3.31% | 4 qtrssince 2018-Q4 | Increased 77 |
FISERV INC | 2.7M | $281.5M | 3.0% | $102.61 | 0.00% | 1 qtr | New 81 |
ALPHABET INC-CL A | 220,434 | $269.2M | 2.8% | $51.94 | +17.14% | 4 qtrssince 2018-Q4 | Decreased 0 |
WALT DISNEY CO/THE | 1.9M | $244.6M | 2.6% | $124.23 | +1.59% | 3 qtrssince 2019-Q1 | Decreased 0 |
ANTHEM INC | 868,027 | $208.4M | 2.2% | $239.87 | -8.90% | 4 qtrssince 2018-Q4 | Decreased 0 |
| 19.3M | $202.4M | 2.1% | $6.17 | +26.78% | 4 qtrssince 2018-Q4 | Increased 53 | |
DAVITA INC | 3.2M | $184.7M | 1.9% | $55.43 | +1.61% | 3 qtrssince 2019-Q1 | Unchanged 0 |
WILLIAMS COS INC | 7.5M | $181.5M | 1.9% | $14.64 | +17.01% | 4 qtrssince 2018-Q4 | Increased 50 |
CBS CORP NEW | 4.1M | $167.1M | 1.8% | — | — | 4 qtrssince 2018-Q4 | Decreased 0 |
LYONDELLBASELL INDU-CL A | 1.8M | $158.1M | 1.7% | $54.01 | +9.16% | 4 qtrssince 2018-Q4 | Decreased 0 |
GLENVIEW CAPITAL MANAGEMENT, LLC manages $9.5B across 49 positions as of Q3 2019. Top holdings: CI (8.2%), HCA (6.8%), MCK (5.8%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 4/5.0.
Active quarter - 9 new positions, 6 exits, 14 increased. Top move: FISV (NEW, conviction 81). Portfolio: $9.5B across 49 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer